The human heart plays a vital role in pumping blood throughout our body to supply oxygen and nutrients to tissues. However, sometimes there can be defects in the heart that need to be corrected through medical procedures. Cardiac implants are emerging as revolutionary solutions to treat various heart conditions. In this article, we will discuss the latest cardiac implant technologies and their potential to transform heart healthcare.
Types of Cardiac Implants
There are different types of implants used depending on the heart condition that needs to be addressed:
Pacemakers: One of the most common cardiac implants is the pacemaker. It is a small, battery-powered device placed under the skin of the chest to help regulate abnormal heart rhythms. Pacemakers are used to treat bradycardia or slow heart rate conditions. Modern pacemakers are more advanced with features like remote monitoring.
Defibrillators: Implantable cardioverter-defibrillators (ICDs) are used to treat life-threatening arrhythmias or irregular heartbeats. They continuously monitor the heart rhythm and can deliver electric shocks to restore normal rhythm if an arrhythmia is detected. ICDs have saved countless lives by terminating ventricular fibrillation.
Heart Valve Implants: For patients with heart valve defects or damage, artificial heart valves made of biological or mechanical materials can be implanted surgically to replace the defective native valves. Common types are mechanical valves, bioprosthetic valves, and valve repair/reconstruction procedures.
Left Ventricular Assist Devices: LVADs are mechanical pumps that help a weak heart pump blood. They are used as a bridge to transplantation for end-stage heart failure patients waiting for a donor heart or may be a permanent destination therapy for those ineligible for a transplant. Advanced miniaturized LVAD models have transformed the lives of heart failure patients.
Cardiac Resynchronization Therapy: Patients with heart failure accompanied by electrical dyssynchrony benefit from CRT devices that pace both lower chambers of the heart simultaneously. CRT helps coordinate the pumping of both ventricles to improve the pumping efficiency of the heart.
Benefits of Cardiac Implants
Cardiac implants have brought tremendous benefits to patients who would otherwise face severe disability or even death from lethal heart conditions:
Improved Quality and Length of Life: Implantable devices precisely monitor heart function and deliver lifesaving electrical therapies or mechanical assistance whenever needed. This has significantly improved survival and quality of life for countless patients.
Reduced Hospitalizations: Regular remote monitoring of implant parameters allows early detection and treatment of potential device or heart-related issues before they escalate, thereby reducing hospital admissions.
Mobility and Independence: Heart patients are no longer limited in their daily activities due to device-managed arrhythmias or mechanical circulatory support. This restores productivity and freedom.
Advanced Technology: The latest implantable devices are much smaller, more reliable, long-lasting, and provide greater diagnostic capabilities compared to older models. Programming and device control have also become very user-friendly.
Cost-Effectiveness: Despite the initial costs of expensive devices and implantation procedures, cardiac implants prove cost-effective in the long run by preempting frequent and expensive hospitalizations from advanced heart disease that would occur otherwise.
Continuous Evolution and Research
The field of cardiac implants is constantly advancing through multidisciplinary research involving engineers, healthcare professionals and industry players:
Miniaturization of Device Components: Manufacturers are finding ways to make batteries, circuit boards and other internals smaller without compromising longevity or function. This has enabled the development of tiny implantable devices.
Advances in Leadless Pacemakers and Implantable Sensors: New generation leadless pacemakers have wireless electrode capabilities and eliminate lead fractures seen with traditional pacemakers. Implantable biosensors monitor multiple cardiac parameters for improved disease management.
Development of Artificial Hearts: Though total artificial hearts are currently used as temporary bridges to transplant, ongoing research aims to develop more durable, long-term artificial hearts as permanent implants. Artificial heart valves are also quickly evolving.
Digitization and Connectivity: Cardiac implants feature advanced computing abilities, Bluetooth connectivity and software for seamless integration with external patient monitoring portals and physician interfaces. This enables remote diagnostics, periodic upgrades and networked care teams.
Biodegradable Implants: Bioresorbable cardiac scaffolds aim to restore blood flow after cardiac procedures and gradually dissolve leaving normal tissue in their place over time, avoiding lifetime device dependency.
Potential of Regenerative Therapies: Stem cell therapies and tissue engineering approaches may someday revolutionize implantable options by enabling regeneration of diseased heart tissues and organs, restoring their natural functioning without mechanical assist devices long-term.
Conclusion
As leading technology firms actively drive innovation in Medtech, implantable solutions signify immense promise in transforming heart healthcare worldwide. They empower patients with debilitating cardiac conditions to lead fuller lives through sophisticated, long-lasting devices monitored remotely by providers. With continuous advancement, future generations may depend less on mechanical interventions through biological solutions. Cardiac implants will surely play a pivotal role in defeating heart diseases in the coming decades.
Market Research Future (MRFR) has announced a new release on the Global Cardiac Implants Market.
The report values the global cardiac implants market at USD 8.91 bn in 2017 and forecasts a steady rise at a 7.2% CAGR over the forecast period from 2018 to 2023.
Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6726 Cardiac Implants Market OverviewCardiac implants are specifically designed to monitor irregular heartbeats in people with heart rhythm disorders.
Such disorders are mainly caused by problems associated with the heart’s electrical system, which signals the heart to pump blood throughout the body.
Devices comprise implantable cardioverter defibrillators, pacemakers, implantable hemodynamic monitoring, cardiac resynchronization therapy, and implantable heart rhythm monitors, which are also referred to as loop recorders.
The global cardiac implants market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 7.82%, surpassing a valuation of USD 38,054.3 million during the forecast period (2020-2023).Global Cardiac Implants Market: Segmental AnalysisThe cardiac implants device market has been segmented on the basis of device, indication, and end users.By device, the market is segmented into prosthetic heart valve devices, coronary stents, and others.By indication, the market is classified into heart failure, arrhythmias, and others.Considering the end use segment, the market is segmented into cardiac care centers, hospitals, and others.
